XPENG-MOTORS
Xpeng Motors, a leading Chinese electric vehicle and technology company, today announced the launch of its P7 super-long range, high-performance, fast-charging intelligent EV sports sedan, its second production model. The P7 is immediately available for order in China, in 3 versions and 8 configurations, and customer deliveries will commence end June 2020, starting at RMB 229,900 – 349,900 (US$32,462 – 49,404) post subsidies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200427005378/en/
“Today is a milestone in the 5-year history of Xpeng Motors,” said He Xiaopeng, Chairman & CEO. “The P7’s launch solidifies Xpeng Motors’ leading position in China’s smart EV market. Our ability to launch the P7 in the challenging conditions of the COVID-19 crisis is a testament to the strength of our young company.”
With superior autonomy and connectivity, the Xpeng P7 incorporates many breakthroughs and firsts. It is the first L3 autonomy-ready production vehicle in the Chinese market. It boasts world-beating NEDC 706km super-long driving range and 4.3s 1-100km/h acceleration in some configurations. It is the first production model in any market worldwide powered by NVIDIA’s DRIVE AGX Xavier system-on-a-chip, delivering 30 TOPS (trillions of operations per second) performance while consuming only 30 watts of power.
Strong performance against key industry benchmarks
- High-performance 3-in-1 electric drive system – compact, light, efficient, reliable – with world-class motor energy density of 2.0 kW/kg and an efficiency up to 97.5%.
- Longest-driving range EV in China at NEDC 706km.
- World’s first EV with Infineon 950 IGBT module, delivering up to 580A to motor for continuous 40s.
- German luxury sports style auto brand joint-developed chassis, optimized suspension & layout.
- Bosch / Brembo braking system, new-gen Bosch iBooster braking recycling, c.100% energy recovery, with 35m 100km/h brake distance.
- Autonomous driving system XPILOT3.0 for China’s challenging roads - 12 ultrasonic sensors, 5 millimeter-wave radars, 14 cameras – industry’s only 360° multi-perception integrated system.
- Qualcomm Snapdragon 820 high-performance auto chip running Xpeng Xmart OS 2.0 - world’s first intelligent full-scenario voice interactive system, integrating App stores and Alipay mini-program dual ecosystem.
- Whole-car OTA upgrade capability for in-car apps as well as ECU-controlled functions, supported by its SEPA (Smart Electric Platform Architecture).
- CATL high-density slim-profile prismatic battery pack, 110mm height, 80.9kWh with energy density reaching 170Wh/kg.
- Fast charging: from 30% to 80% charge as fast as 28 mins, 120km range in 10 mins; with China’s first remote-controlled concealed charging plug.
- 5-level safety design: Passive, battery, active, air quality and data security measures.
Market-leading autonomous driving architecture
The Xpeng P7 has the strongest autonomous driving architecture among production vehicles in China. Powered by NVIDIA's DRIVE Xavier, the P7 operates both the XPILOT3.0 and XPILOT2.0 systems concurrently to provide complete redundancy. The XPILOT3.0 reaches high levels of Functional Safety to offer guaranteed stability and security. As the foundation of the Xpeng P7s technology, the safety framework is designed and benchmarked to C-NCAP 5-star standards.
The P7’s multiple front-facing, side and rear-facing cameras cover a 180°-degree+ field of view, following tight curves and recognizing vehicles cutting in at close quarters. The P7 is equipped with the industry’s first new-generation forward-looking millimeter wave radar sensors, with detection distance over 200 meters, offering market-leading accuracy and angle of view, effectively penetrating rain, fog, haze to perceive surroundings in reduced visibility conditions. Four more high-performance millimeter wave radars are positioned at each corner of the P7 – an industry-leading configuration.
The P7’s lane-level positioning function is backed by AutoNavi’s high-definition high-precision maps with high-level accuracy. The GPS/RTK/IMU positioning hardware allows positioning accuracy to the centimeter level, or less than 0.3% thanks to real-time positioning map construction technology (SLAM). These complementary features effectively enhance the stability and safety of the P7’s autonomous driving function on overpasses, in tunnels or under bad weather conditions. Coupled with the precise control capabilities brought by Bosch iBooster, the P7 performs a suite of advanced ADAS functions, including navigation-guided pilot (NGP) for highways, traffic light recognition assistance and the first production model to feature memory parking for car parks.
Superior style and support
As well as high technology, the P7 boasts superior styling and ergonomic features designed to enrich and enhance the driving experience. The bodywork is crafted with an elegant minimalist profile that lowers air resistance to a market-leading Cd0.236, delivering longer range and a quieter, smoother ride.
The intelligent cockpit is designed to interact with driver and passengers through voice commands, infotainment, and a concert hall-standard 600w Dynaudio surround-sound audio environment. A panoramic glass roof, frameless doors, and a low-profile console offer wide-angle views in all directions. Nappa leather styling is available for that extra touch of luxury.
The P7 will be available through Xpeng’s growing sales network, already some 113 outlets across 57 cities, and its service network of 73 stores in 52 cities. Supercharging stations for the P7 have already reached 164 contracted and signed units across 35 cities, while its supporting 3rd-party charging pile networks number some 200,000+ units across China.
“Our philosophy of end-to-end closed-loop R&D is what sets us apart among China’s intelligent EV manufacturers,” Chairman He concluded. “Regular OTA upgrades will ensure that the P7 continues to grow and improve as we do.”
The Xpeng P7 is immediately available in China in various configurations, starting from RMB 229,900 – 349,900 (US$32,462 – 49,404) post subsidies.
4WD High Performance (4.3s 0-100km/h acceleration): RMB 339,900 – 349,900
RWD Super-Long Range: (656km – 706km NEDC): RMB 254,900 – 276,900
RWD Long Range (568km NEDC) RMB 229,900 – 259,900
(All post subsidies)
For Xpeng P7’s videos and images please visit : https://183.236.41.237
Log-in name: xpfilelv2
Password: xpfile@P7@
About XPENG Motors
Xpeng Motors is a leading Chinese electric vehicle company that designs and manufactures automobiles that are seamlessly integrated with the Internet and utilize the latest advances in artificial intelligence. The company's initial backers include its Chairman & CEO, He Xiaopeng, who’s also the co-founder of UCWeb Inc. and a former Alibaba executive. Established in 2014, Xpeng Motors has a senior management team with diverse backgrounds, including Co-founders Henry Xia and He Tao, both former senior executives at Guangzhou Auto with expertise in innovative automotive technology and R&D, and Vice Chairman & President Brian Gu, former Chairman of Asia Pacific Investment Banking at J.P. Morgan. It has received funding from strategic investors Alibaba Group and Xiaomi Corporation, as well as other prominent Chinese and international investors including IDG Capital, Morningside Venture Capital, GGV Capital and Primavera Capital. The company launched its first production model, the G3 SUV, in Dec 2018, and will launch its second production model, the P7 electric sports sedan, in April 2020 with deliveries to Chinese customers in Q2 2020. Xpeng Motors is headquartered in Guangzhou, China with offices in Beijing, Shanghai, Silicon Valley and San Diego in the U.S. and manufacture centers in Zhengzhou and Zhaoqing. For more information, please visit the official website: https://en.xiaopeng.com/
Follow us on social media for latest Xpeng news:
Facebook
Twitter
LinkedIn
YouTube
Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20200427005378/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Avanzanite Bioscience Secures €32M Series A Investment from MVM Partners18.11.2025 07:00:00 CET | Press release
MVM Partners joins as Avanzanite’s first institutional investor. Funding will scale Avanzanite’s existing infrastructure in all 32 countries in Europe, propel current launches, and support further product alliances and acquisitions. In just 3 years, Avanzanite has entered 3 strategic alliances and actively launched 3 rare disease medicines. Avanzanite’s Q3 2025 revenue tripled year-on-year and climbed over 20% quarter-on-quarter. Avanzanite is a unique, fully integrated partner for biotech and pharma innovators seeking to market and distribute their rare disease medicines in Europe. A new pan-European standard is being set for orphan medicine launches and patient access, with no one left behind. Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 million Series A growth investment from MVM Partners (MVM), a leading global life-science private equity firm. This press release
Over 30 Million Users Benefit From Ant International’s Bettr Credit Tech Solutions18.11.2025 04:35:00 CET | Press release
Powering the Next Wave of MSME Growth with Digital Platforms in Emerging MarketsThere was a threefold year-on-year increase in eligible customers reached through partners using Bettr's credit tech solutions by the end of October 2025.The solution features an AI-driven, alternative-data-powered credit engine that can help partner platforms to cut credit policy deployment from weeks to minutes.Partnership with Dock, a leading Brazilian payments and banking technology provider, will expand the deployment of Bettr’s credit tech solutions. Bettr, a leading provider of inclusive financial services and technology business under Ant International, today announced the launch of its proprietary tailored, one-stop credit tech solutions designed to help digital platforms build and scale their lending businesses to better serve micro, small and medium enterprises (MSMEs) in emerging markets. Bettr's credit tech solutions supported over 30 million customers to gain access to credit services through
Ant International Deepens Participation in Project Ensemble as New Architecture Community Member18.11.2025 04:00:00 CET | Press release
Ant International has been a participant in the Ensemble Sandbox since 2024 Ant International today announced it has joined Project Ensemble’s Architecture Community to support the design and advancement of Hong Kong’s tokenisation ecosystem. As a Community member, it will be more involved in defining industry standards and supporting the development of Hong Kong’s tokenisation market, together with the Hong Kong Monetary Authority (HKMA) and leading peers. A fintech representative on the Community, Ant International will also contribute its technological and innovation capabilities in tokenisation to support broader industry adoption. This comes at a time when Project Ensemble reaches a new milestone with EnsembleTX, which will see it move from sandbox experiments to live market use within a pilot environment. Through EnsembleTX, Ant International will continue to broaden its partnerships with banks and other committee members, contributing to real-world use cases of tokenisation in r
Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg18.11.2025 03:51:00 CET | Press release
Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in EuropeOmlyclo™ 300 mg/2ml prefilled syringe (PFS) presentation is now approved in EU offering a simpler dosing schedule and improved patient adherence The European Commission (EC) has granted a line extension in the European Union (EU) for Celltrion’s Omlyclo™ (omalizumab), Europe’s first and only omalizumab biosimilar, for the 300 mg/2ml prefilled syringe (PFS).The European Commission (EC) approved Omlyclo™ 75 mg/0.5ml and 150mg/1ml solution for injection in pre-filled syringe in May 2024. Omlyclo™ is indicated for the treatment of patients with allergic asthma, chronic spontaneous urticaria (CSU) and chronic rhinosinusitis with nasal polyps (CRSwNP). “The additional strength of Omlyclo™ 300mg can significantly decrease the frequency of injections, and reduce injection burden and discomfort, without compromising efficacy and safety,” said Nam Lee, Vice President of Global Medical Affairs at Celltrion. “These
2026 Mitsui Chemicals Catalysis Science Awards18.11.2025 03:00:00 CET | Press release
Online applications are open until December 25, 2025 Mitsui Chemicals, Inc. has announced that online applications for the 2026 Mitsui Chemicals Catalysis Science Award have been open since September 1, 2025. The application period will run from September 1 to December 25, 2025. Aiming to contribute to the sustainable development of chemistry and the chemical industry, Mitsui Chemicals established the Mitsui Chemicals Catalysis Science Awards in 2004. The awards consist of the Catalysis Science Award and the Catalysis Science Award for Creative Work, which recognize outstanding achievements in the field of catalysis science. To date, the awards have been conferred on 33 researchers within Japan and overseas. Past recipients include individuals who have gone on to be highly acclaimed worldwide, receiving honors such as the Nobel Prize in Chemistry and other prestigious Japanese and international awards. We welcome applications from a wide range of R&D fields, including solid catalysts,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
